Vitestro Raises $70 Million to Advance Autonomous Blood Collection Robot

Mar 12, 2026
Vitestro has closed a $70 million Series B funding round to support development and commercialization of its Aletta Autonomous Robotic Phlebotomy Device, with participation from Labcorp Venture Fund, Mayo Clinic, and Sutter Health.

Dutch medical robotics company Vitestro has raised $70 million in an oversubscribed Series B round to advance its autonomous robotic blood collection system, announced in a press release. The funding includes new strategic investments from Labcorp Venture Fund, Mayo Clinic, and Sutter Health, alongside financial investors such as InterVest, MGFO, PGGM, Puma Venture Capital, and ROM Utrecht.

The proceeds will be used to further develop the next-generation Aletta Autonomous Robotic Phlebotomy Device (ARPD), expand clinical and manufacturing operations, and prepare for global commercialization. Vitestro also plans to pursue U.S. FDA De Novo regulatory clearance as it progresses from European market entry toward the U.S.

Aletta uses multimodal imaging, robotics, and artificial intelligence to identify veins, guide needle insertion, and collect samples autonomously. The device is designed to standardize blood collection quality, support clinical workflows, and reduce staffing pressures in high-volume outpatient settings.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like AI Funding Brief, Robotics Brief or Daily AI Brief.

Also, consider following us on social media:

AI Funding News AI & Robotics AI Brief AI Brief (X)
Free newsletter

Robotics Brief

Weekly coverage of AI-driven robotics advances in industrial automation, autonomous vehicles, and robotic systems.

Guide
Private humanoid makers by latest disclosed equity round

Private humanoid makers by latest disclosed equity round

Thirteen independent humanoid robot makers, ordered by the size of their latest disclosed round

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.